Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of levamlodipine besylate + benazepril hydrochloride capsules in primary hypertension uncontrolled after benazepril monotherapy
CTR20242838Phase 3Active
- Sponsor
- Jiangxi Shimei Pharmaceutical
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Levamlodipine, benazepril in essential hypertension, sponsored by Jiangxi Shimei Pharmaceutical. Started Oct 2024; status: active.
02
Drugs
Levamlodipinebenazepril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20242838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242838.